Quantifying Gains in Data Quality for Sampling Plans Used in Clinical Trial Monitoring

被引：0
作者：
Dennis W. King
Melynda Hazelwood
机构：
[1] STATKING Consulting,
[2] Inc.,undefined
来源：
Drug information journal : DIJ / Drug Information Association | 2003年 / 37卷
关键词：
Data quality; Data management; Quality assurance; Continuous sampling plans; Clinical monitoring;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Clinical study monitoring is the first level of quality assurance checks on clinical trials data. The clinical study monitor goes to the study site and compares the case report forms to the source documents. Because some clinical trials are very large, the monitor may not be able to do a 100% check of all case report forms versus their corresponding source document. This paper will examine three possible sampling plan scenarios for monitoring case report forms in large studies.
引用
收藏
页码：135 / 141
页数：6
相关论文
共 25 条
  • [1] Quantifying gains in data quality for sampling plans used in clinical trial monitoring
    King, DW
    Hazelwood, M
    DRUG INFORMATION JOURNAL, 2003, 37 (02): : 135 - 141
  • [2] Heterogeneity in clinical research data quality monitoring: A national survey
    Houston, Lauren
    Yu, Ping
    Martin, Allison
    Probst, Yasmine
    JOURNAL OF BIOMEDICAL INFORMATICS, 2020, 108
  • [3] Clinical researchers’ lived experiences with data quality monitoring in clinical trials: a qualitative study
    Lauren Houston
    Ping Yu
    Allison Martin
    Yasmine Probst
    BMC Medical Research Methodology, 21
  • [4] Clinical researchers' lived experiences with data quality monitoring in clinical trials: a qualitative study
    Houston, Lauren
    Yu, Ping
    Martin, Allison
    Probst, Yasmine
    BMC MEDICAL RESEARCH METHODOLOGY, 2021, 21 (01)
  • [5] An In-Process Scaling Model: A Potential Framework for Data Monitoring Committees and Clinical Trial Quality Improvement
    Alan Smith
    Jonathan Seltzer
    Drug information journal : DIJ / Drug Information Association, 2012, 46 : 8 - 12
  • [6] An In-Process Scaling Model: A Potential Framework for Data Monitoring Committees and Clinical Trial Quality Improvement
    Smith, Alan
    Seltzer, Jonathan
    DRUG INFORMATION JOURNAL, 2012, 46 (01): : 8 - 12
  • [7] Quantifying the magnitude and cost of collecting nice-to-have clinical trial data
    Stergiopoulos, Stella
    Surgeon, Leon
    Getz, Kenneth A.
    CHIMICA OGGI-CHEMISTRY TODAY, 2016, 34 (6A) : 48 - 51
  • [8] Overcoming challenges to data quality in the ASPREE clinical trial
    Jessica E. Lockery
    Taya A. Collyer
    Christopher M. Reid
    Michael E. Ernst
    David Gilbertson
    Nino Hay
    Brenda Kirpach
    John J. McNeil
    Mark R. Nelson
    Suzanne G. Orchard
    Kunnapoj Pruksawongsin
    Raj C. Shah
    Rory Wolfe
    Robyn L. Woods
    Trials, 20
  • [9] Overcoming challenges to data quality in the ASPREE clinical trial
    Lockery, Jessica E.
    Collyer, Taya A.
    Reid, Christopher M.
    Ernst, Michael E.
    Gilbertson, David
    Hay, Nino
    Kirpach, Brenda
    McNeil, John J.
    Nelson, Mark R.
    Orchard, Suzanne G.
    Pruksawongsin, Kunnapoj
    Shah, Raj C.
    Wolfe, Rory
    Woods, Robyn L.
    TRIALS, 2019, 20 (01)
  • [10] Improving Data Quality in Medical Research: A Monitoring Architecture for Clinical and Translational Data Warehouses
    Spengler, Helmut
    Gatz, Ingrid
    Kohlmayer, Florian
    Kuhn, Klaus A.
    Prasser, Fabian
    2020 IEEE 33RD INTERNATIONAL SYMPOSIUM ON COMPUTER-BASED MEDICAL SYSTEMS(CBMS 2020), 2020, : 415 - 420
123